Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Yes-associated Protein Induces Age-dependent Inflammatory Signaling in the Pulmonary Endothelium
Memet T Emin1, Alexandra M Dubuisson1,2, Prisha Sujin Kumar1
1Pediatric Critical Care, Hospitalist, and Palliative Medicine, Department of Pediatrics, Columbia University Irving Medical Center.
Insights
Acute Lung Injury (ALI) involves inflammatory signaling in adult mice, dependent on Yes-associated protein (YAP), but not in weanlings. YAP blockade protected adult mice, suggesting age-dependent pathways for Acute Respiratory Distress Syndrome (ARDS) therapies.
Area of Science:
- Pulmonary Medicine
- Cellular Signaling
- Inflammation Research
Background:
- Acute Lung Injury (ALI) leads to lethal Acute Respiratory Distress Syndrome (ARDS) with limited therapeutic options.
- Pediatric ARDS (PARDS) exhibits lower mortality than adult ARDS, suggesting age-related physiological differences.
- Rodent models show improved ALI measures in juvenile animals, hinting at distinct pathophysiological mechanisms.
Purpose of the Study:
- To investigate age-dependent differences in lung endothelial inflammatory signaling during ALI.
- To identify key molecular pathways involved in ALI pathophysiology in adult versus juvenile mice.
- To explore the role of Yes-associated protein (YAP) in ALI-induced inflammation.
Main Methods:
- Induction of pneumonia-induced ALI in adult and weanling mice.
- Analysis of endothelial inflammatory signaling, focusing on YAP.
- Transcriptomic analysis of lung endothelial cells to identify differential gene expression.
- Assessment of nuclear factor kappa-B (NF-κB) activation.
- Pharmacological blockade of YAP signaling.
Main Results:
- Pneumonia-induced ALI triggered YAP-dependent inflammatory signaling in adult mouse lung endothelium, absent in weanlings.
- Transcriptomic analysis revealed significantly increased NF-κB signaling in adult ALI lungs compared to weanlings.
- Blockade of YAP signaling ameliorated inflammatory responses, hypoxemia, and NF-κB translocation in adult mice with ALI.
- A distinct signaling cascade in adult lung endothelium during ALI was identified.
Conclusions:
- An age-dependent YAP-NF-κB signaling cascade in the lung endothelium contributes to ALI pathophysiology in adult mice.
- This pathway is not present in weanling mice, explaining potential differences in ALI/ARDS outcomes.
- Targeting age-specific pathways like YAP signaling may lead to novel therapeutic strategies for ARDS in different age groups.
Abstract:
Acute Lung Injury (ALI) causes the highly lethal Acute Respiratory Distress Syndrome (ARDS) in children and adults, for which therapy is lacking. Children with Pediatric ARDS (PARDS) have a mortality rate that is about half of adults with ARDS. Improved ALI measures can be reproduced in rodent models with juvenile animals, suggesting that physiologic differences may underlie these outcomes. Here, we show that pneumonia-induced ALI caused inflammatory signaling in the endothelium of adult mice which depended on Yes-associated protein (YAP). This signaling was not present in 21-day-old weanling mice. Transcriptomic analysis of lung endothelial responses revealed nuclear factor kappa-B (NF-κB) as significantly increased with ALI in adult versus weanling mice. Blockade of YAP signaling protected against inflammatory response, hypoxemia, and NF-κB nuclear translocation in response to Pseudomonas aeruginosa pneumonia in adult mice. Our results demonstrate an important signaling cascade in the lung endothelium of adult mice that is not present in weanlings. We suggest other pathways may also exhibit age-dependent signaling, which would have important implications for ARDS therapeutics in the adult and pediatric age groups.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammation
The JAK-STAT Signaling Pathway

